Catherine Stehman-Breen, Chroma Medicine CEO
Epigenetic editing startup Chroma lays off staff, focusing on reaching the clinic
Chroma Medicine laid off an undisclosed number of employees earlier this week, as the privately held startup focuses its resources on moving its first epigenetic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.